SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2
Titel:
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2
Auteur:
Pandey, Kabita Acharya, Arpan Pal, Dhananjaya Jain, Prashant Singh, Kamal Durden, Donald L. Kutateladze, Tatiana G. Deshpande, Aniruddha J. Byrareddy, Siddappa N.